The PROMID study group now reports that octreotide LAR (long-acting release) has a substantial antitumor effect, with longer progression-free survival compared with placebo in patients with well ...

Hikma recently received the Food and Drug Administration’s permission for a new generic, and the company also launched two new generic products. The FDA approved Hikma's first generic ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...